Interventions for Tuberculosis Control and Elimination 2002

392. Feldman WH, Hinshaw HC. Effects of streptomycin on experimental tuberculosis
in guinea pigs: a preliminary report. Mayo Clin Proc 1944; 19: 593-9.
393. Hinshaw HC, Feldman WH. Streptomycin in treatment of clinical tuberculosis:
a preliminary report. Mayo Clin Proc 1945; 20: 314-8.
394. Feldman WH, Hinswaw C, Mann FC. Streptomycin in experimental tuberculosis.
Am Rev Tuberc 1945; 52: 269-98.
395. Hinshaw HC, Feldman WH, Pfuetze KH. Treatment of tuberculosis with streptomycin.
JAMA 1946; 132: 778-82.
396. Crowle AJ, Sbarbaro JA, Judson FN, Douvas GS, May MH. Inhibition by streptomycin
of tubercle bacilli within cultures human macrophages.
Dis 1984; 130: 839-44.
Am Rev Respir
397. Moazed D, Noller HF. Interaction of antibiotics with functional sites in 16S
ribosomal RNA. Nature 1987; 327: 389-94.
398. Mitchison DA. The segregation of streptomycin-resistant variants of
Mycobacterium tuberculosis into groups with characteristic levels of resistance.
J Gen Microbiol 1951; 5: 596-604.
399. Rinder H, Mieskes KT, Löscher T. Heteroresistance in Mycobacterium tuberculosis.
Int J Tuberc Lung Dis 2001; 5: 339-45.
400. Honoré N, Cole ST. Streptomycin resistance in mycobacteria. Antimicrob Agents
Chemother 1994; 38: 238-42.
401. Holdiness MR. Chromatographic analysis of antituberculosis drugs in biological
samples. J Chromatography 1985; 340: 321-59.
402. Douglas JG, McLeod MJ. Pharmacokinetic factors in the modern drug treatment
of tuberculosis. Clin Pharmacokinetics 1999; 37: 127-46.
403. Johnston RN, Smith DH, Lockhart W, Ritchie RT. Optimal dose of streptomycin
in pulmonary tuberculosis. BMJ 1961; 1: 105.
404. Morris JT, Cooper RH. Intravenous streptomycin: a useful route of administration.
Clin Infect Dis 1994; 19: 1150-1.
405. Johnston RN, Smith DH, Ritchie RT, Lockhart W. Prolonged streptomycin and
isoniazid for pulmonary tuberculosis. BMJ 1964; 1: 1679-83.
406. Pfaltz CR, Herzog H, Staub H, Wey W. Zur ototoxischen Wirkung hoher
Streptomycindosen. Schweiz Med Wochenschr 1960; 90: 1472-8.
407. Jahrmärker H. Ueber Desensiblilisierung bei Streptomycin-Allergie des
Pflegepersonals. Aerztl Wochenschrift 1955; 10: 873-6.
408. Holdiness MR. Neurological manifestations and toxicities of the antituberculosis
drugs. A review. Med Toxicol 1987; 2: 33-51.
409. Paradelis AG, Triantaphyllidis CJ, Mironidou M, Crassaris LG, Karachalios DN,
Giala MM. Interaction of aminoglycoside antibiotics and calcium channel blockers
at the neuromuscular junction.
687-90.
Meth Find Exptl Clin Pharmacol 1988; 10:
195